Penis Enlargement (Girth Surgery)
A related method involves injection of silicone, PMMA, and other materials into the penis and scrotum, to achieve penis girth enlargement. The results of the study into penis augmentation surgery confirm that surgical techniques used to thicken the penis are far more effective than those designed to increase penile length.
n the research sample of men studied, flaccid circumference following the above procedure had increased from an average of 3.1 inches to an average of 4.1 inches, whilst erect penile circumference increased from an average of 4.1 inches before surgery to 4.8 inches after surgery.
Some have even shrunk, but is effectively irreversible and may have side effects including loss of sensation, inability to perform penetrative intercourse, scarring, and deformation.
In 2006, the journal of European Urology reported autologous tissue engineering using biodegradable scaffolds as beneficial not only for men with penile dysmorphic disorder and for correcting severe penile shaft deformity after lipofilling but also an advanced, well-proven therapeutic approach for penile girth enhancement with remarkable safety, reproducibility, superior cosmetic results, low morbidity, and low incidence of post-operative complications.
Unlike the high level of dissatisfaction with lengthening cited in the opening paragraph of this article, 81% of patients scored the results of autologous tissue engineering as "excellent" and "very good" with most experiencing a 4 cm (1.6 inches) permanent flaccid girth gain.
Unlike the injection or implantation of foreign substances into the penis such as AlloDerm, silicone, and other substances, tissue culture leaves no residual foreign tissue around the penis after scaffold reabsorption by the body.
Although AlloDerm (treated donated flesh) is currently being used by some plastic surgeons, its manufacturer does not recommend it for penis enlargement phalloplasty.
The U.S. Food and Drug Administration (FDA) regulates its use and has specifically not approved AlloDerm as a "void filler" nor for "cosmetic augmentation".
The manufacturer warns phalloplasty surgeons that it is: "important to clarify ... cosmetic augmentation phalloplasty does not fall within approved procedures for which LifeCell can promote AlloDerm".
In 2002, an FDA approved method was developed by urologists in Beverly Hills, California using a subcutaneous, silicone implant to permanently increase both girth and length in the penis simultaneously.
The surgeon inserts a semi-soft silicone implant between the penile skin and the corpora. The implant is soft and covered with mesh on one end to fix and hold it beneath the glans.
The implant constantly stretches the penis, promoting gains in length, while simultaneously (and immediately) increasing the girth. With a silicone implant, patients generally see gains of 1 ½ to 2 ½ inches in both length and girth.
The procedure takes less than an hour to perform in an outpatient surgery center. The patient is able to return to light activity like walking immediately, and return to work in 3–5 days following surgery; full recovery time totals six to eight weeks.
The subcutaneous silicone implant also increases length over time. Once inside the penis, the weight of the implant gently pulls down on the penis, stretching the suspensory ligament, and promoting permanent length gains of up to two inches without the use of vacuums or devices.
Another major advantage of this method is the option for total removal, which procedures like Alloderm and Fat fillers do not allow. The silicone implant is also non-absorbable, unlike Alloderm and fat fillers.
This technique was presented for the first time at the American Urology Association Western Division and also the American Society of Sexual Medicine by Dr. James Elist, of Southern California